EFFECTIVENESS OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS: A COMBINED ANALYSIS OF REAL-WORLD EVIDENCE

被引：0
|
作者：
Cummings, Fraser
Buisson, Anthony
Smith, Philip J.
Rahmany, Sohail
Subramanian, Sreedhar
Kwon, Buki
Park, Soyeon
Lee, Young Nam
Fumery, Mathurin
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1854
引用
收藏
页码：S1144 / S1144
页数：1
相关论文
共 50 条
  • [41] BIOSIMILAR INFLIXIMAB SWITCHING IS NOT ASSOCIATED WITH ADVERSE OUTCOMES: A REAL-WORLD EFFECTIVENESS ANALYSES IN A NATIONAL COHORT OF US MILITARY VETERANS WITH INFLAMMATORY BOWEL DISEASE
    Hou, Jason K.
    Pham, Codey
    Sansgiry, Shubhada
    Modi, Varsha
    Waljee, Akbar K.
    GASTROENTEROLOGY, 2023, 164 (06) : S645 - S646
  • [42] Effectiveness of Upadacitinib for Inflammatory Bowel Disease Patients With Pouchitis: Prospective Real-World Experience
    Cleveland, Noa Krugliak
    Choi, Natalie
    Choi, David K.
    Dalal, Sushila
    Rubin, David T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S873 - S874
  • [43] Long-term effectiveness and acceptability of switching from intravenous to subcutaneous infliximab in patients with inflammatory bowel disease treated with intensified doses: The REMSWITCH-LT study
    Buisson, A.
    Nachury, M.
    Bazoge, M.
    Yzet, C.
    Wils, P.
    Dodel, M.
    Coban, D.
    Pereira, B.
    Fumery, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (04) : 526 - 534
  • [44] Switching from Intravenous to Subcutaneous Biological Therapy for Inflammatory Bowel Disease Patients Remains a Challenge
    Richter, Vered
    Cohen, Daniel L.
    Kriger-Sharabi, Ofra
    Zelnik Yovel, Dana
    Kochen, Nadav
    Broide, Efrat
    Shirin, Haim
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [45] Long-term Efficacy and Persistence of Subcutaneous Infliximab after Switching from Intravenous Infliximab in patients with Crohn's disease: A Real-World Multicenter Prospective Cohort Study in Korea
    Kim, K.
    Hong, S. N.
    Kang, S. B.
    Lee, K. M.
    Koo, J. S.
    Jung, Y.
    Yoon, H.
    Lee, B. J.
    Lee, H. S.
    Lee, Y. J.
    Lim, Y. J.
    Lee, J.
    Lee, C. K.
    Shin, S. Y.
    Moon, J. M.
    Seo, J.
    Lim, H.
    Choi, C. H.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1466 - I1467
  • [46] Therapeutic Drug Monitoring for Dose Optimization of Infliximab in Patients With Inflammatory Bowel Disease: An Analysis of Canadian Real-World Data
    Sealey, David C.
    Ho, Kai Fai
    Zhou, Z. Christina
    Clark, Michael
    Feagan, Brian G.
    Panaccione, Remo
    Steinhart, A. Hillary
    Bolshtyansky, Elena
    Williamson, Martin
    Afif, Waqqas
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2025, 2025 (01)
  • [47] Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure
    Bae, J. H.
    Park, J. B.
    Baek, J. E.
    Hong, S. W.
    Park, S. H.
    Yang, D. H.
    Ye, B. D.
    Byeon, J. S.
    Myung, S. J.
    Yang, S. K.
    Hwang, S. W.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1131 - I1133
  • [48] Effectiveness of Switching to Subcutaneous Infliximab in Ulcerative Colitis Patients Experiencing Intravenous Infliximab Failure
    Bae, June Hwa
    Park, Jung-Bin
    Baek, Ji Eun
    Hong, Seung Wook
    Park, Sang Hyoung
    Yang, Dong-Hoon
    Ye, Byong Duk
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    Hwang, Sung Wook
    GUT AND LIVER, 2024, 18 (04) : 667 - 676
  • [49] Efficacy and safety of elective switching of inflammatory bowel disease patients from intravenous to subcutaneous infliximab (IFX): a multi-centre cohort study
    Smith, P. J.
    Storey, D.
    Gregg, B.
    Critchley, L.
    Stenson, J.
    Kneebone, A.
    Rimmer, T.
    Burke, S.
    Hussain, S.
    Teoh, W. Y.
    Vazeille, S.
    Serna, S.
    Bond, A.
    Steel, A.
    Dibb, M.
    Collins, P.
    Derbyshire, E.
    Bodger, K.
    Probert, C.
    Verma, A.
    Subramanian, S.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S480 - S481
  • [50] Clinical efficacy and durability of subcutaneous infliximab in patients with inflammatory bowel disease after switching from intravenous in a Korean multicenter prospective cohort study
    Kim, K.
    Hong, S. N.
    Kang, S. B.
    Lee, K. M.
    Koo, J. S.
    Jung, Y.
    Lee, B. J.
    Yoon, H.
    Kim, H. W.
    Lim, Y. J.
    Lee, H. S.
    Lee, Y. J.
    Lee, J.
    Lee, C. K.
    Shin, S. Y.
    Moon, J. M.
    Seo, J.
    Choi, C. H.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1007 - I1009
12345